
AMCP is your partner in navigating AI’s transformative potential—ensuring patient-centered, ethically sound, and strategically aligned implementation across pharmacy practice and policy.
AMCP sends letter to Congressional Leadership asking for the inclusion of 42 CFR Part 2 provisions and Medicare Fraud Waste and Abuse protections in a final opioid conference report.
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.